Urine pH and Urinary Tract Infection

NCT ID: NCT04598971

Last Updated: 2020-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-01

Study Completion Date

2021-12-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Urinary tract infections (UTI) affect the urine pH and may lead to salt precipitation such as struvite. Bacteria with urease activity are known to alkalinise urine, but not much is known on how pH is changing over time during UTI.

This study aims at following urine pH progression at the time of diagnosis of UTI and during the treatment phase.

Description of the change in urine pH over time will help understanding the risk of struvite formation and potential timing of intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adults presenting with UTI symptoms will be screened for infection and instructed to monitor urine pH during the course of treatment and 1 week after. Urine pH will be measured by the patients using calibrated pH-stix. Type of bacteria, antibiotics, and the type of diet will be monitored during the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infections Urinary Stone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cystitis

Patients with lower UTI will be included in this group

No interventions assigned to this group

Pyelonephritis

Patients with higher UTI will be included in this group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symptoms of dysuria, pollakiuria, no fever AND
* urine-stix positive for leucocytes OR positive culture (\>10E5 cfu/ml)

Group 2. Pyelonephritis


* Unilateral flank pain, pollakiuria, dysuria, fever (\>38.5°C) AND
* urine-stix positive for leucocytes OR positive culture (\>10E5 cfu/ml)

Exclusion Criteria

* known urinary tract anatomic abnormalities
* Presence of a urine catheter
* Sepsis - septic shock
* Patient taking drug interfering with urine pH (diuretics, citrate, acetazolamide, topiramate,...)
* Patients with UTI diagnosed in the preceding month
* Patients having received antibiotics during the preceding month
* Male patient with a diagnosis of prostatitis
* Presence of infected kidney cyst
* Patient with diabetes
* Pregnant female
* Patient with obstructive pyelonephritis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Olivier Bonny

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Olivier Bonny, MD-PhD

Role: PRINCIPAL_INVESTIGATOR

CHUV-Lausanne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UniSanté

Lausanne, Canton of Vaud, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Charlotte Desponds, BM

Role: CONTACT

+41795561934

Alexandre Gouveia, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexandre Gouveia, MD

Role: primary

+41213144905

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-00779

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Urine Alkalinization for UTI in Women: RCT
NCT07202832 NOT_YET_RECRUITING NA